242: Pharmacogenetics Determinants of Anticancer Activity of Intravescical Gemcitabine in Patients with Superficial Transitional Cell Carcinoma (TCC) of The Bladder

Authors :: D. Matel Victor
Umberto Besana
Bernardo Rocco
Marcelo Pimentel
Gennaro Musi
E. Scardino
Giuseppe Curigliano
de Cobelli Ottavio
Sara Nanizzi
Elisa Giovanetti
de Braud Filippo
Romano Danesi
Gianluca Spitaleri
Eduardo Pedroso
F. Verweij
Stefano Zambito
Salvatore Pece
Valentina Mey
Source :: Journal of Urology. 177:81-81
Publication Year :: 2007
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2007.

Subjects :: Transitional cell carcinoma
business.industry
Urology
Cancer research
Medicine
In patient
business
medicine.disease
Pharmacogenetics
Gemcitabine
medicine.drug

Full Text Access

Tools